Many Young South African Women, U.S. MSM, Thai Transgender Women In Study Adhere To Daily PrEP Regimen

New York Times: Daily HIV Drug Regimen Is Effective in African Women, Study Says
“…The study, called ADAPT, found that wide majorities of young women in Cape Town, South Africa — as well as [transgender women] in Bangkok and younger gay men in Harlem — were willing and able to take the [antiretroviral] pills daily. Previous studies have shown that taking the drug, called Truvada, faithfully every day provides nearly perfect protection against HIV, even in people having regular unsafe sex…” (McNeil, 7/22).

NIH: Young South African women can adhere to daily PrEP regimen as HIV prevention
“…Although some previous placebo-controlled PrEP clinical trials in women in sub-Saharan Africa had found challenges with adherence, 76 percent of women assigned to take PrEP on a daily basis in the HIV Prevention Trials Network (HPTN) 067 study adhered to the prescribed regimen. MSM and [transgender women (TGW)] from Harlem and Bangkok who participated in the study adhered to the daily regimen 65 percent and 85 percent of the time, respectively…” (7/21).

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.